🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 032797300
- Market Cap
- Mid Cap
Business: Anavex Life Sciences Corp. is a biopharmaceutical company dedicated to the development of novel drug candidates to treat Alzheimer’s disease, other central nervous system (CNS) diseases, pain, and various types of cancer. Anavex’s lead drug candidate, ANAVEX 2-73, is currently in a Phase 2a clinical trial for Alzheimer’s disease.
Company Contact
- CEO
- Christopher U. Missling, PhD
- CFO
- Christopher Missling, PhD
- Headquarters
- 630 5th Avenue, 20th Floor, New York, NY USA 10111
- Phone
- 844-689-3939 · Toll-Free 844-689-3939
- Investor Relations
- 866-505-2895 · ir@anavex.com